Las Vegas, NV -- (SBWIRE) -- 10/15/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), U.S. Auto Parts Network, Inc. (NASDAQ:PRTS), Bioline RX Ltd (NASDAQ:BLRX), Frontline Ltd. (NYSE:FRO)
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) was a volume gainer of 1.00 million shares and the average volume of the stock remained 565,864 shares. The stock opened the session at $8.70 and finished at the end of the day at $8.16 and the stock plunged -7.27%.The market capitalization of the stock remained 343.70 million. The half-yearly trend of the stock remained positive 35.32 %. AcelRx Pharmaceuticals, Inc. is a United States-based Pharmaceutical Company, which develops and commercializes therapies for the treatment of pain. The Company's products include ARX-01 Sufentanil NanoTab PCA System, to solve the problems associated with post-operative intravenous patient-controlled analgesia (IV PCA); ARX-02 Sufentanil NanoTab BTP Management System is a treatment option for cancer patients who suffer from breakthrough pain (BTP).
Has ACRX Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, U.S. Auto Parts Network, Inc. (NASDAQ:PRTS) exchanged 89,663 shares and the average volume remained 264,727 shares. The stock closed the session at $1.76 with the drop of -6.88%. Tracking three months and 6 months trends, the stock was at of 70.87% and -6.88%, respectively. U.S. Auto Parts Network, Inc. (U.S. Auto Parts) offers online sources for automotive aftermarket parts and repairs information. The Company principally sells its products, identified as stock keeping units (SKUs), to individual consumers through its network of Websites and online marketplaces. The Company's Websites provide customers with a selection of approximately two million SKUs with product descriptions and photographs.
Why Should Investors Buy PRTS After the Recent Fall? Just Go Here and Find Out
Bioline RX Ltd (NASDAQ:BLRX) decreased -6.71% and its closing price was $2.78. The volume of the stock was 179,791 shares and the average volume remained 162,915 shares. Yesterday, the stock traded amid the day price range of $2.65 - $2.97. The market capitalization of the stock remained 70.30 million. BioLineRX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in schizophrenia patients; BL-1040, which is under pivotal CE-Mark registration trial for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, which has completed Phase I/II clinical trials for non-surgical removal of skin lesions; BL-1021 that has completed Phase Ia clinical trial for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is in Phase II clinical trial for the treatment of inflammatory bowel disease.
Will BLRX Get Buyers Even After The Recent Rally? Find Out Here
Frontline Ltd. (NYSE:FRO) exchanged 2.00 million shares in the previous trading session, and its average trading remained 1.31 million shares. FRO dropped -6.67 % and it closed the trading at $2.10. The market capitalization of the stock remained 164.88 million. YTD trend of the stock was negative -34.17%. Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker. The Company operates oil tankers of two sizes: Very Large Crude Carriers (VLCCs), which are between 200,000 and 320,000 deadweight tonnages (dwt), and Suezmax tankers, which are vessels between 120,000 and 170,000 dwt.
Will FRO Bounce Back After yesterday’s Sharp Sell off? Find Out Here
About:Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)